Medical News

RSS

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the neoadjuvant setting had an overall response rate of 75 percent in the absence of anastrozole and 63 percent in combination with anastrozole, according to results from the phase II TRIO-US B-12 TALENT trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

Study identifies characteristics linked with higher likelihood of post COVID-19 condition diagnosis

Many studies have described a variety of long-term effects of COVID-19, with symptoms including fatigue and malaise, breathing difficulties, and cognitive problems, often referred to as post COVID-19 condition or long COVID.

7 Dec 2022

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

In a recent Morbidity and Mortality Weekly Report (MMWR), the United States Center for Disease Control and Prevention (U.S.-CDC) published the preliminary results of the National Health and Nutrition Examination Survey (NHANES) for August 2021–May 2022.

7 Dec 2022

Study reveals biological mechanism to explain why respiratory viruses spike in colder seasons

Researchers at Mass Eye and Ear and Northeastern University have discovered a previously unidentified immune response inside the nose that fights off viruses responsible for upper respiratory infections.

7 Dec 2022

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

Researchers attempted to establish an association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load, indicating its ribonucleic acid (RNA) levels, and the presence of infectious virions.

7 Dec 2022

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

Researchers identified risk factors for and the prevalence of persistent pulmonary tissue alterations among hospitalized coronavirus disease 2019 (COVID-19) patients.

7 Dec 2022

LabVantage Solutions Launches Version 8.8 of its Flagship LIMS Platform

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced the launch of version 8.8 of its industry-leading LabVantage LIMS platform.

From LabVantage Solutions 7 Dec 2022

Owlstone Medical Presents Breath Biopsy® VOC Atlas

Owlstone Medical has embarked on an exciting project to better understand the diversity of molecules in a given breath sample

From Owlstone Medical Ltd 7 Dec 2022

New ASTRO guideline provides recommendations on the use of radiation therapy for endometrial cancer

A newly updated clinical guideline from the American Society for Radiation Oncology provides recommendations on the use of radiation therapy and systemic therapy after surgery to treat patients with endometrial cancer.

7 Dec 2022

Study: People with higher levels of vitamin D in the brain have better cognitive function

An estimated 55 million people worldwide live with dementia, a number that's expected to rise as the global population ages.

7 Dec 2022

Genomic assay can help identify breast cancer patients who may benefit from ovarian suppression therapy

Among premenopausal women with hormone receptor (HR)-positive, early-stage breast cancer enrolled in the SOFT trial, those with a high score on a genomic assay called Breast Cancer Index (BCI) had increased risk of distant recurrence, and those with low BCI benefited more from the addition of ovarian suppression therapy to endocrine therapy after 12 years of follow-up, according to data presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

Grenova Earns ISO 9001:2015 and ISO 13485:2016 Certification as Part of Its Mission to Manufacture Green Technology

Grenova, creator of the laboratory industry’s only patented technology for washing and reusing plastic consumables, announced today that it has earned ISO 9001:2015 and ISO 13485:2016 certification as part of the company’s mission to make laboratories around the world sustainable, resilient, cost-effective, and highly efficient.

From Grenova 7 Dec 2022

Metrion Biosciences and The KCNC1 Foundation Collaborate on New Ion Channel Modulators

...

From Metrion Biosciences Limited 7 Dec 2022

New method can easily detect multiple types of cancers

When cancer is detected at an early stage, the rates of survival increase drastically, but today only a few cancer types are screened for.

7 Dec 2022

Oral bacteria may be a contributory factor in patients developing brain abscesses

Bacteria known to cause oral infections may also be a contributory factor in patients developing potentially life-threatening abscesses on the brain, new research has shown.

7 Dec 2022

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Researchers evaluated the immunogenicity, boosting efficacy, and safety of single-dose and two-dose MVA-BN (modified vaccinia Ankara-Bavarian Nordic) vaccinations in comparison to replicating smallpox vaccines.

7 Dec 2022

Air pollution-triggered immune surveillance deficits in the lungs increase the risk of respiratory diseases with aging

Researchers highlighted the significance of air quality in preserving immune health over the human lifespan, especially lung-related immunity, owing to the lungs' continuous exposure to the environment.

7 Dec 2022

Watch: Big Medicaid changes in California leave millions of patients behind

KHN senior correspondent Angela Hart appeared on Spectrum News 1's "Los Angeles Times Today" on Nov. 29 to discuss her reporting on California's pricey and ambitious experiment to transform its Medicaid program, called Medi-Cal.

7 Dec 2022

Paxlovid has been free so far. Next year, sticker shock awaits.

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with covid-19 from being hospitalized or dying, and it may even reduce the risk of developing long covid.

7 Dec 2022

Colorado option’s big test: Open enrollment

Critics declared Colorado's new quasi-public option a failure this fall, before it was even available for purchase on the state's Affordable Care Act health insurance marketplace.

7 Dec 2022

Medical News

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Study identifies characteristics linked with higher likelihood of post COVID-19 condition diagnosis

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

Study reveals biological mechanism to explain why respiratory viruses spike in colder seasons

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

LabVantage Solutions Launches Version 8.8 of its Flagship LIMS Platform

Owlstone Medical Presents Breath Biopsy® VOC Atlas

New ASTRO guideline provides recommendations on the use of radiation therapy for endometrial cancer

Study: People with higher levels of vitamin D in the brain have better cognitive function

Genomic assay can help identify breast cancer patients who may benefit from ovarian suppression therapy

Grenova Earns ISO 9001:2015 and ISO 13485:2016 Certification as Part of Its Mission to Manufacture Green Technology

Metrion Biosciences and The KCNC1 Foundation Collaborate on New Ion Channel Modulators

New method can easily detect multiple types of cancers

Oral bacteria may be a contributory factor in patients developing brain abscesses

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Air pollution-triggered immune surveillance deficits in the lungs increase the risk of respiratory diseases with aging

Watch: Big Medicaid changes in California leave millions of patients behind

Paxlovid has been free so far. Next year, sticker shock awaits.

Colorado option’s big test: Open enrollment

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News